Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Regeneron and Society for Science selected The Frazer School senior Sophia Rong as a finalist in the Regeneron Science Talent Search 2025. Rong was the only finalist from this area, and one of 40 from ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

You pay a one-off fee per logo, the price of which varies depending on the features you require (such as a transparent background or social media designs), and if you need the ability to amend ...

Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...

Facilities for Regeneron Canada in thriving Mississauga/GTA biotech hub signal its growth and readiness to bring more of its life-transforming innovative medicines for serious diseases to ...

Salvador Panelo, after President Ferdinand Marcos Jr. said Duterte was “lying” for claiming that the 2025 General Appropriations Act contained “blank” items. Ungab previously alleged ...

Parang binigyan ka ng blanking cheke diyan [at] bahala na kayo ano ilagay ninyo, (why the budget that arrived your way was blank. It’s like you were given a blank check [and] it’s up to you what you ...

Mibavademab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Acquired Generalized Lipodystrophy (Lawrence Syndrome). According to GlobalData, Phase II drugs for ...

With a market cap of $77.3 billion, Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company dedicated to discovering, developing, and commercializing innovative treatments for a ...

Regeneron Pharmaceuticals Inc.'s executives and board members overstated its key eye treatment’s average selling price, prompting a Department of Justice enforcement action and exposing the drugmaker ...